We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
AusPAR: mRESVIA
Australian Public Assessment Report
Device/Product Name
mRESVIA
Active ingredients
Respiratory syncytial virus F protein mRNA (nucleoside modified) vaccine
AusPAR Date
Published
Sponsor
Submission Number
PM-2023-02734-1-2
Submission Type
New biological entity
Decision
Approved